Meeting
2023 ASCO Annual Meeting
Clinical genomic implications of transcriptional subtypes in pancreatic cancer.
Authors
Harshabad Singh
Dana-Farber Cancer Institute, Brookline, MA
Harshabad Singh , Kevin S Kapner , Joanne Xiu , Matthew James Oberley , Alex Patrick Farrell , Jimmy Guo , Rishi Surana , Kimberly Perez , James M. Cleary , Srivatsan Raghavan , Benjamin Adam Weinberg , Michael J. Pishvaian , Rachna T. Shroff , Sanjay Goel , Stephanie Dougan , Jonathan Nowak , David Spetzler , George W. Sledge Jr., Brian M. Wolpin , Andrew Aguirre
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer - Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4145)
DOI
10.1200/JCO.2023.41.16_suppl.4145
Abstract #
4145
Poster Bd #
466
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Molecular and clinical correlates of DSCR1 expression in pancreatic cancer (PDAC).
First Author: Francesca Battaglin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterization of the cachexia pathway in pancreatic ductal adenocarcinoma.
First Author: Karam Ashouri
Poster
2022 ASCO Annual Meeting
Comprehensive characterization of PTPRT expression in colorectal cancer (CRC).
First Author: Francesca Battaglin
Poster
2023 ASCO Annual Meeting
Not all treated KRAS-mutant pancreatic adenocarcinomas are equal: KRAS G12D and survival outcome.
First Author: Bach Ardalan